Medicenna Therapeutics Corp (MDNAF)

$0.59 -0.01 (-2.15%)
Market Cap 50.05M
Revenue (ttm) 0.00
Net Income (ttm) -8.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 51,900
Avg Vol 128,934
Day's Range N/A - N/A
Shares Out 83.41M
Stochastic %K 7%
Beta 1.81
Analysts Strong Sell
Price Target $2.96

Company Profile

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15...

Industry: Biotechnology
Sector: Healthcare
Phone: 416 648 5555
Address:
2 Bloor Street West, Suite 903 7th Floor, Toronto, Canada
Usmccbr
Usmccbr May. 14 at 7:48 PM
$MDNAF Now it’s time for good news. Ready and waiting.
0 · Reply
Lytnup
Lytnup May. 14 at 3:04 PM
$MDNAF Looks like Bloom has worked with Medicenna before; more than a few of the companies they’ve funded are listed north of the border. Tidbit of unrelated information - Satellos is listed several times, and is the home of Ms Elizabeth Williams, former CFO for Medicenna…. https://www.bloomburton.com/service/raising-capital-and-financing/
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 14 at 2:44 PM
$MDNAF we’ve been lower
1 · Reply
boomshiva
boomshiva May. 14 at 1:42 PM
$MDNAF Och!
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 14 at 1:05 PM
$MDNAF
0 · Reply
rudazur2
rudazur2 May. 13 at 10:01 PM
$MDNAF they need at least 20M$ but we are at a marketcap of less than 40M... How they will do that
3 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 13 at 9:14 PM
$MDNAF Can’t believe they got it to this point! Obviously zero interest in 55 nor in anything else. Sad
0 · Reply
_Osmium
_Osmium May. 13 at 8:03 PM
$MDNAF Here comes the offering. TORONTO and HOUSTON , May 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, announced today the launch of a marketed public offering (the “Offering”) of securities of the Company (the “Securities”).
2 · Reply
_Osmium
_Osmium May. 12 at 11:19 AM
$MDNAF Today's press release was standard practice but now Dr. Merchant can focus elsewhere. I find that significant. Here is the quote: “Dosing the first patient in the NEO-CYT study represents an important milestone in the continued clinical development of MDNA11 and expands our evaluation of this next-generation IL-2 Superkine into the neoadjuvant setting,” said Dr. Nageatte Ibrahim, Chief Medical Officer of Medicenna.
2 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:18 AM
$MDNAF Great seeing some comments from the rock-star CMO Dr. Nageatte Ibrahim!!!
1 · Reply
Latest News on MDNAF
No data available.
Usmccbr
Usmccbr May. 14 at 7:48 PM
$MDNAF Now it’s time for good news. Ready and waiting.
0 · Reply
Lytnup
Lytnup May. 14 at 3:04 PM
$MDNAF Looks like Bloom has worked with Medicenna before; more than a few of the companies they’ve funded are listed north of the border. Tidbit of unrelated information - Satellos is listed several times, and is the home of Ms Elizabeth Williams, former CFO for Medicenna…. https://www.bloomburton.com/service/raising-capital-and-financing/
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 14 at 2:44 PM
$MDNAF we’ve been lower
1 · Reply
boomshiva
boomshiva May. 14 at 1:42 PM
$MDNAF Och!
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 14 at 1:05 PM
$MDNAF
0 · Reply
rudazur2
rudazur2 May. 13 at 10:01 PM
$MDNAF they need at least 20M$ but we are at a marketcap of less than 40M... How they will do that
3 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 13 at 9:14 PM
$MDNAF Can’t believe they got it to this point! Obviously zero interest in 55 nor in anything else. Sad
0 · Reply
_Osmium
_Osmium May. 13 at 8:03 PM
$MDNAF Here comes the offering. TORONTO and HOUSTON , May 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, announced today the launch of a marketed public offering (the “Offering”) of securities of the Company (the “Securities”).
2 · Reply
_Osmium
_Osmium May. 12 at 11:19 AM
$MDNAF Today's press release was standard practice but now Dr. Merchant can focus elsewhere. I find that significant. Here is the quote: “Dosing the first patient in the NEO-CYT study represents an important milestone in the continued clinical development of MDNA11 and expands our evaluation of this next-generation IL-2 Superkine into the neoadjuvant setting,” said Dr. Nageatte Ibrahim, Chief Medical Officer of Medicenna.
2 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:18 AM
$MDNAF Great seeing some comments from the rock-star CMO Dr. Nageatte Ibrahim!!!
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 12 at 11:09 AM
$MDNAF Neo-Cyt Begins! Results should start rolling in a few months!! https://ir.medicenna.com/news-releases/news-release-details/medicenna-and-fondazione-melanoma-onlus-announce-first-patient
1 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor May. 11 at 7:47 PM
$MDNAF Hopefully a good-priced offering coming? Or pump before the offering...
0 · Reply
Lytnup
Lytnup May. 11 at 6:46 PM
$MDNAF Only need another 10 days like this to get back to the 52-week high…..not saying that’s where it should stay, but just sayin’…..
2 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 11 at 6:38 PM
$MDNAF and down she goes….
0 · Reply
rudazur2
rudazur2 May. 11 at 6:00 PM
$MDNAF asco in 3 weeks or future offering take your bet for today action move
0 · Reply
Lytnup
Lytnup May. 11 at 5:47 PM
$MDNAF have to admit, it’s kind of fun to watch; not very often do I see the bid above the ask, & last trade above both…..
0 · Reply
Vikingess
Vikingess May. 11 at 3:02 PM
$MDNAF why is this "up" today?
2 · Reply
Lytnup
Lytnup May. 11 at 2:23 PM
$MDNAF It’s been a bit since I have seen this for any ticker symbol
0 · Reply
Pramdizzle
Pramdizzle May. 10 at 9:40 PM
$MDNAF is the asymmetric upside still present here? I have a small position. Others holding for an upcoming catalyst?
0 · Reply
bobwut12
bobwut12 May. 7 at 8:23 PM
$MDNAF I feel like the price is inversely proportional to the amount that David writes about their science.
0 · Reply
Lytnup
Lytnup May. 7 at 3:39 PM
$MDNAF Mr. Bakke has been busy https://open.substack.com/pub/davidbakke/p/the-illusion-of-control-part-1-when?r=10wt7d&utm_medium=ios https://open.substack.com/pub/davidbakke/p/prism-11-key-refractions-the-illusion?r=10wt7d&utm_medium=ios
1 · Reply
Lytnup
Lytnup May. 7 at 12:09 PM
$MDNAF Never heard of Locust Walks, but their new venture sounds timely…… https://www.linkedin.com/posts/andy-meyerson-1036562_todaywereproud-to-announce-the-launch-activity-7457454578184187904-ufDQ?utm_medium=ios_app&rcm=ACoAAAsnC8EBAcKQyUEEvVrkPzTEpnlOSa2bgnk&utm_source=social_share_send&utm_campaign=copy_link
1 · Reply